Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer
NCT ID: NCT02867644
Last Updated: 2022-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
171 participants
INTERVENTIONAL
2016-11-17
2020-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard care
standard care
Patients coming for preoperative breast assessment will have standard care.
standard care+conversational hypnosis
standard care + conversational hypnosis
Patients coming for preoperative breast assessment will have standard care with conversational hypnosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard care
Patients coming for preoperative breast assessment will have standard care.
standard care + conversational hypnosis
Patients coming for preoperative breast assessment will have standard care with conversational hypnosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
* Patient undergoing for a preoperative breast assessment
* Patient must be affiliated to a social security system
* Ability to provide an informed written consent form
Exclusion Criteria
* Patients with schizophrenia
* Patients do not understand the French language
* Pregnant or breast feeding females
* Refusal of the patient to participate in the study
* Persons deprived of liberty or under supervision
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Cancérologie de Lorraine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
HENROT Philippe, MD
Role: PRINCIPAL_INVESTIGATOR
Institut de Cancérologie de Lorraine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Bastia
Bastia, , France
Chu Bordeaux-Pellegrin
Bordeaux, , France
CHRU de Brest
Brest, , France
Centre Léon Bérard
Lyon, , France
APHM La Timone
Marseille, , France
Centre Paul Strauss
Strasbourg, , France
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lemoine L, Adam V, Galus X, Siles P, Coulon A, Grenier-Desforges J, Orabona J, Kergastel I, Wagner P, Salleron J, Tosti P, Huin-Schohn C, Merlin JL, Etienne R, Henrot P. Conversational hypnosis versus standard of care to reduce anxiety in patients undergoing marker placement under radiographic control prior to breast cancer surgery: A randomized, multicenter trial. Front Psychol. 2022 Nov 22;13:971232. doi: 10.3389/fpsyg.2022.971232. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A00232-49
Identifier Type: -
Identifier Source: org_study_id